| 2024/08/06 21:59:33 | |
|---|---|
| Price | |
| 0.75 USD | |
| Difference | -1.19% (-0.01) |
General attributes
| ISIN | NL0010391025 |
| Symbol | PHARM |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 487 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 0.75 USD |
| High | 0.75 USD |
| Low | 0.75 USD |
| Close (prev. day) | 0.759 USD |
| VWAP | 0.75 USD |
| Volume (pcs) | 769 |
| Trading volume | 576.75 |
| Number of trades | 1 |
| Last size | 769 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: PHARMING GROUP N.V. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/08/06 21:59:33 | |
|---|---|
| Price | |
| 0.75 USD | |
| Difference | -1.19% (-0.01) |
General attributes
| ISIN | NL0010391025 |
| Symbol | PHARM |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 487 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 0.75 USD |
| High | 0.75 USD |
| Low | 0.75 USD |
| Close (prev. day) | 0.759 USD |
| VWAP | 0.75 USD |
| Volume (pcs) | 769 |
| Trading volume | 576.75 |
| Number of trades | 1 |
| Last size | 769 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -41.86% | -39.52% | -34.78% |
| Perf (abs.) | -0.54 | -0.49 | -0.40 |
| Beta | 1.29 | 0.98 | 0.82 |
| Volatility | 91.53 | 93.71 | 92.85 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.77 USD (4,400) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.80 USD (1,737) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 0.86 USD (600) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 1.03 USD (1,087) |
| YTD High | date | 1.29 USD (2024/01/30) |
| YTD Low | date | 0.75 USD (2024/07/29) |
| 52 Weeks High | date | 1.40 USD (2023/09/21) |
| 52 Weeks Low | date | 0.75 USD (2024/07/29) |
All listings for PHARMING GROUP N.V.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/08/07 | 10:00 | 0.73 EUR | 0.01 | 10 |
| Stuttgart | 2024/08/07 | 12:25 | 0.7305 EUR | 0.00 | 5 |
| Munich | 2024/08/07 | 08:18 | 0.702 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/08/07 | 08:59 | 0.729 EUR | 0.00 | 1 |
| Frankfurt | 2024/08/07 | 08:08 | 0.71 EUR | 0.00 | 1 |
| FINRA other OTC Issues | 2024/08/06 | 21:59 | 0.75 USD | 0.00 | 1 |
| Euronext Amsterdam | 2024/08/07 | 12:56 | 0.733 EUR | 1.49 | 572 |
| Duesseldorf | 2024/08/07 | 08:10 | 0.7025 EUR | 0.00 | 1 |
| Berlin | 2024/08/07 | 08:18 | 0.7035 EUR | 0.00 | 1 |
Company Logo
Contact Details
| PHARMING GROUP NV |
| - - |
| Darwinweg 24 - 2333 CR Leiden |
| Telefon: +31-71-524-74-00 |
| Fax: + |
| E-mail: info@pharming.com |
PDF Downloads
| Company report: PHARMING GROUP N.V. | |
Company Profile
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands. |
Members of Management Board
| Sijmen de Vries | Chairman of Managing Board |
| Alexander Breidenbach | Member of Executive Committee |
| Anurag Relan | Member of Executive Committee |
| Jeroen Wakkerman | Member of Executive Committee |
| Mireille Sanders | Member of Executive Committee |
| Ruud van Outersterp | Member of Executive Committee |
| Stephen Toor | Member of Executive Committee |
Board of directors
| Richard Peters | Chairman of Supervisory Board |
| Jabine T. M. van der Meijs | Member of Supervisory Board |
| Mark Pykett | Member of Supervisory Board |
| Barbara Yanni | Member of Supervisory Board |
| Deborah Jorn | Member of Supervisory Board |
| Leonard Kruimer | Member of Supervisory Board |
| Steven Baert | Member of Supervisory Board |